Rani Therapeutics Holdings Inc Total Assets
Rani Therapeutics Holdings Inc total assets. Based on the latest financial reports, Rani Therapeutics Holdings Inc (RANI) holds total assets worth $60.84 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see RANI market cap for the company's overall valuation and market capitalisation.
Total Assets of Rani Therapeutics Holdings Inc (2019–2025)
Total assets of Rani Therapeutics Holdings Inc from 2019 to 2025. This chart illustrates how Rani Therapeutics Holdings Inc's total assets have evolved over time, based on quarterly financial data. See Rani Therapeutics Holdings Inc stock quote for real-time trading data and today's change.
Rani Therapeutics Holdings Inc - Asset Composition Analysis
Rani Therapeutics Holdings Inc Total Assets Breakdown (December 2025)
Rani Therapeutics Holdings Inc total assets breakdown as of December 2025. Rani Therapeutics Holdings Inc's total assets of $60.84 Million consist of 91.0% current assets and 9.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 31.8% |
| Accounts Receivable | $2.04 Million | 3.5% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how Rani Therapeutics Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore RANI working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Rani Therapeutics Holdings Inc's current assets represent 91.0% of total assets in 2025, an increase from 73.6% in 2019.
- Cash Position: Cash and equivalents constituted 31.8% of total assets in 2025, down from 71.8% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 3.5% of total assets.
Rani Therapeutics Holdings Inc Competitors by Total Assets
Key competitors of Rani Therapeutics Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hyloris Developmentsen Sa
BR:HYL
|
Belgium | €37.05 Million |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Oruka Therapeutics, Inc.
NASDAQ:ORKA
|
USA | $1.14 Billion |
|
Gempharmatech Co. Ltd. A
SHG:688046
|
China | CN¥2.80 Billion |
|
Vor Biopharma Inc
NASDAQ:VOR
|
USA | $481.05 Million |
|
Inventiva S.A
PA:IVA
|
France | €249.51 Million |
|
Sunmax Biotechnology Co Ltd
TWO:4728
|
Taiwan | NT$1.90 Billion |
|
Apnimed, Inc. Common Stock
NASDAQ:APMD
|
USA | $342.63 Million |
Rani Therapeutics Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.31 | 0.54 | 25.21 |
| Quick Ratio | 5.31 | 0.54 | 25.21 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $45.88 Million | $-9.55 Million | $127.11 Million |
Rani Therapeutics Holdings Inc - Advanced Valuation Insights
This section examines the relationship between Rani Therapeutics Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.42 |
| Latest Market Cap to Assets Ratio | 1.09 |
| Asset Growth Rate (YoY) | 60.0% |
| Total Assets | $58.62 Million |
| Market Capitalization | $64.15 Million USD |
Valuation Analysis
Above Book Valuation: The market values Rani Therapeutics Holdings Inc's assets above their book value (1.09x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Rani Therapeutics Holdings Inc's assets grew by 60.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Rani Therapeutics Holdings Inc (2019–2025)
The table below shows the annual total assets of Rani Therapeutics Holdings Inc from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $58.62 Million | +60.02% |
| 2024-12-31 | $36.63 Million | -36.75% |
| 2023-12-31 | $57.92 Million | -46.39% |
| 2022-12-31 | $108.03 Million | -13.03% |
| 2021-12-31 | $124.21 Million | +56.40% |
| 2020-12-31 | $79.42 Million | +244.95% |
| 2019-12-31 | $23.02 Million | -- |
About Rani Therapeutics Holdings Inc
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug subst… Read more